• AMPK, ULK1, and the Energy Stress Response

  2026-08-18

  The reference study challenges the prevailing view that AMPK universally promotes autophagy during glucose deprivation. Its experiments show that AMPK suppresses ULK1 signaling during severe energy stress while preserving the autophagy machinery for later recovery, establishing a context-dependent model of energy-stress adaptation.

• AMPK, ULK1, and Autophagy Under Energy Stress

  2026-08-18

  The reference study challenges the prevailing view that AMPK uniformly stimulates autophagy during glucose deprivation. Using pathway-specific signaling and autophagy readouts, it shows that AMPK suppresses ULK1-driven autophagy during acute energy stress while preserving the autophagy machinery for recovery after stress is relieved.

• Isoproterenol Sulfate Dihydrate: Assay Guide

  2026-08-17

  A scenario-based guide to using Isoproterenol sulfate dihydrate in viability, proliferation, cytotoxicity, and human pacemaker models. It explains how SKU C6402 can improve interpretation through controlled dosing, compatible formulation, and documented quality attributes.

• Intestinal TM6SF2 and the Gut–Liver Axis in MASH

  2026-08-17

  This study shows that intestinal epithelial TM6SF2 protects against MASH by preserving barrier function and controlling host–microbiota interactions, rather than acting only through hepatic lipid metabolism. Its genetic, microbiome-transfer and pharmacological experiments identify gut-derived lysophosphatidic acid as a mechanistic link between intestinal TM6SF2 deficiency and liver steatohepatitis.

• A-769662: Interpreting AMPK Signals in Cell Stress

  2026-08-16

  A-769662 is a reversible AMPK activator that can separate energy-sensing kinase activity from nutrient-starvation effects. This guide connects its metabolic and proteasome-related pharmacology with revised autophagy biology to improve assay design and interpretation.

• Nurr1 Neurogenetic Gradients in Rat Claustrum

  2026-08-15

  Fang, Wang, and Naumann mapped when Nurr1-positive neurons emerge across the rat claustrum, endopiriform nucleus, and lateral cortex. By combining developmental Nurr1 in situ hybridization with EdU birthdating, the study identifies sequential neurogenesis and regional gradients that refine anatomical interpretations of the rodent claustrum.

• CA-074: Mapping Cathepsin B in Lysosomal Death

  2026-08-14

  CA-074 is a selective cathepsin B inhibitor for resolving how lysosomal protease release contributes to necroptosis, cancer metastasis, neurotoxicity, and immune response modulation. This article translates recent MLKL–lysosome findings into practical assay and interpretation strategies.

• Sulfo-NHS-SS-Biotin for Protein Turnover Studies

  2026-08-14

  Sulfo-NHS-SS-Biotin connects selective amine labeling with reversible affinity workflows. This guide explains how its cleavable disulfide chemistry can support topology-aware protein purification and interpretation of mitochondrial proteostasis experiments.

• 20-HETE–TRPV1 Signaling in Chronic Dermatitis

  2026-08-13

  The reference study identifies a peripheral mechanism by which chronic dermatitis converts capsaicin-evoked nociceptive signaling into combined itch and pain. Its experiments connect elevated lesional 20-HETE with TRPV1 activation in sensitized MrgprA3+ neurons, providing a mechanistic rationale for targeting this pathway in chronic itch research.

• Tetracycline Workflows for Selection and Ribosome Studies

  2026-08-13

  Tetracycline supports more than routine bacterial selection: it enables controlled growth-inhibition screens, ribosomal function research, and cleaner validation of engineered biological systems. This practical guide connects product handling and assay design with the LKB1–telomerase findings reported in lung adenocarcinoma research, while clearly separating established use from exploratory cross-domain applications.

• Isoproterenol Sulfate Dihydrate in SAN Assays

  2026-08-12

  Use Isoproterenol sulfate dihydrate to convert human SAN-plexus assembloids into a controllable model of beta-adrenergic stress. The workflow distinguishes acute GPCR-driven rate responses from slower innervation-associated maturation, helping researchers connect electrophysiology, cAMP/PKA signaling, and cardiac tissue organization.

• LTI6426 Enhances Panobinostat in Multiple Myeloma

  2026-08-12

  Robinson and colleagues report that the protein disulfide isomerase inhibitor LTI6426 markedly increases the antimyeloma activity of low-dose panobinostat in cell and mouse models, including a proteasome-inhibitor-resistant setting. The combination converges on endoplasmic-reticulum stress effectors, providing a mechanistic rationale for dose-sparing panobinostat regimens and nominating ATF3, DDIT3/CHOP, and DNAJB1 as candidate pharmacodynamic biomarkers.

• Human SAN-Plexus Assembloids Model Pacemaker Maturation

  2026-08-11

  This Cell Stem Cell study develops human pluripotent stem cell-derived assembloids that connect sinoatrial node, cardiac plexus, and atrial-like cardiac tissues to model innervation-associated pacemaker maturation. Functional analyses combined with human SAN spatial transcriptomics identify a CGPO-derived prosaposin–GPR37 signaling program that links neural input to pacemaker phenotype and conduction.

• Lysis Buffer for Reliable Mouse Genotyping

  2026-08-11

  This scenario-based guide explains how SKU H1002, Lysis buffer, components of the rapid genotyping kit for mouse tail, supports consistent genomic DNA release from mouse tail, toe, and ear tissue. It connects practical genotyping quality control with interpretation of downstream viability, proliferation, cytotoxicity, and translational studies while clearly separating product-supported evidence from local validation needs.

• Alosetron in 5-HT3 Gut Signaling Research

  2026-08-10

  Alosetron is a selective 5-HT3 receptor antagonist used as a research perturbation for serotonin receptor pharmacology, gastrointestinal motility modulation, and visceral pain signaling research. The compound provides a receptor-level tool for intestinal models, but current CDC42-YAP-EGF-mTOR evidence does not directly establish that Alosetron controls epithelial polarity or stem cell fate.

15105 records 1/1007 page Next 12345 下5页 Last page